Intratect

Human Normal Immunoglobulin, the active ingredient in Intratect, is an immunoglobulin presented as an injection solution for intravenous use. It provides passive immunity and is used to replace deficient IgG in patients with primary or secondary immunodeficiency diseases, as well as in certain autoimmune and inflammatory conditions.

GNH USA supplies Intratect as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Intratect is an intravenous immunoglobulin that replaces missing antibodies and modulates immune activity in several immune‑related disorders. - Primary immunodeficiency diseases: restores IgG levels to reduce infection frequency. - Secondary immunodeficiency: supplies pooled antibodies to support immune recovery. - Idiopathic thrombocytopenic purpura (ITP): raises platelet counts by immune modulation. - Kawasaki disease: reduces coronary artery inflammation in acute phases. - Chronic inflammatory demyelinating polyneuropathy (CIDP): improves nerve function by attenuating autoimmune attack.

Intratect may cause a range of infusion‑related reactions, most of which are mild and transient.

Common Side Effects: - Headache: mild to moderate discomfort during or after infusion. - Fever or chills: transient rise in body temperature. - Nausea: occasional upset stomach. - Fatigue: feeling of tiredness post‑infusion.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Thromboembolic events: blood clots that may affect veins or arteries. - Renal failure: acute kidney injury, especially with high infusion rates. - Aseptic meningitis: inflammation of meninges without infection. - Hemolysis: destruction of red blood cells leading to anemia.

Before using Intratect, clinicians should assess patient risk factors and monitor for potential complications. - Renal function: evaluate baseline kidney status and hydrate patients to reduce renal risk. - IgA deficiency: screen for anti‑IgA antibodies to avoid severe allergic reactions. - Thrombotic risk: consider history of clotting disorders before infusion. - Premedication: use antihistamines or acetaminophen to lessen infusion reactions. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Intratect can interact with other therapies, influencing efficacy or safety.

Major Interactions (Avoid): - Live vaccines: may diminish vaccine effectiveness. - Rituximab: concurrent use can reduce IVIG benefit. - Additional immunoglobulin products: risk of overload and hyperviscosity.

Moderate Interactions (Monitor Closely): - Anticoagulants: increased risk of thrombosis. - Diuretics: heightened chance of renal impairment. - ACE inhibitors: potential for severe hypotension during infusion.